Related Experiment Video

Updated: Aug 21, 2026

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells
11:46

Ex Vivo Culture of Primary Human Fallopian Tube Epithelial Cells

Published on: May 9, 2011

Mechanisms of hormone-mediated carcinogenesis of the ovary

Charles C Capen1

  • 1Department of Veterinary Biosciences, The Ohio State University, Columbus, Ohio 43210, USA. capen.2@osu.edu

Toxicologic Pathology
|October 27, 2004
PubMed

Insights

Sterility in mice, caused by factors damaging ovarian follicles, leads to hormonal imbalances and increased ovarian tumor risk. These mouse models show unique tubular adenomas not seen in human females.

Area of Science:

  • Reproductive biology
  • Oncology
  • Toxicology

Background:

  • Experimental ovarian carcinogenesis research explores various induction methods in mice.
  • Ovarian lesions, including tumors, arise from disruptions in graafian follicle function.
  • Sterility-associated hormonal changes are implicated in mouse ovarian tumorigenesis.

Purpose of the Study:

  • To investigate mechanisms of experimental ovarian carcinogenesis in mice.
  • To understand the role of hormonal mediation in ovarian tumor development.
  • To compare mouse ovarian responses to human counterparts.

Main Methods:

  • Utilizing inbred and hybrid mouse strains.
  • Employing diverse carcinogenic mechanisms (X-irradiation, chemicals, grafting, genetic mutations, aging).
  • Analyzing hormonal feedback loops involving estradiol and luteinizing hormone (LH).

Main Results:

  • Factors diminishing graafian follicles cause reduced estradiol-17beta secretion.
  • This leads to compensatory overproduction of pituitary gonadotrophins (LH).
  • Increased LH drives ovarian surface epithelium and stromal cell proliferation, forming unique tubular adenomas.

Conclusions:

  • A secondary, hormonally mediated mechanism contributes to ovarian tumorigenesis in sterile mice.
  • The observed tubular adenomas in mice lack a direct parallel in adult human females.
  • Mouse models provide insights into hormonal influences on ovarian cancer but highlight interspecies differences.

More Related Videos

Transplantation Into the Mouse Ovarian Fat Pad09:25

Transplantation Into the Mouse Ovarian Fat Pad

Published on: September 7, 2016

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time14:25

Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time

Published on: May 20, 2014

Related Concept Videos

Hormonal Control of the Ovarian Cycle01:30

Hormonal Control of the Ovarian Cycle

The ovarian cycle is meticulously regulated by the hypothalamic-pituitary-gonadal axis. This cycle orchestrates the release of a mature oocyte, essential for reproduction.
Before puberty, the hypothalamus releases GnRH in a low frequency, low amplitude pulsatile manner. This along with the immature hypothalamic-pituitary-gonadal axis activity, results in low estrogen levels and the absence of a fully functional ovarian cycle.  At puberty, GnRH secretion increases in both frequency and...
Oogenesis02:07

Oogenesis

In human women, oogenesis produces one mature egg cell or ovum for every precursor cell that enters meiosis. This process differs in two unique ways from the equivalent procedure of spermatogenesis in males. First, meiotic divisions during oogenesis are asymmetric, meaning that a large oocyte (containing most of the cytoplasm) and minor polar body are produced as a result of meiosis I, and again following meiosis II. Since only oocytes will go on to form embryos if fertilized, this unequal...
Oogenesis01:22

Oogenesis

Oogenesis,  the process of developing egg cells (female gametes), occurs within the ovaries and is fundamental to female fertility. This sequence begins during fetal development when diploid oogonia in the developing ovaries undergo mitotic divisions to produce primary oocytes. By birth, these primary oocytes enter prophase I of meiosis but become arrested in this stage, remaining suspended until puberty.
Each primary oocyte is surrounded by a layer of pre-granulosa cells, forming what is known...
Hormonal Regulation of the Menstrual Cycle01:22

Hormonal Regulation of the Menstrual Cycle

The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH release.
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...